35
Views
3
CrossRef citations to date
0
Altmetric
Original

Aetiology, diagnosis and therapyof sexually transmitted and allied infections—reflections on novel observations and current trends

Pages 169-174 | Published online: 06 Jul 2009

References

  • Mårdh P-A. How widely spread are STDs? Need for improvement in surveillance systems, interpretations of test results and screening programmes, as exemplified by genital chlamydial infection. Rev Gynaecol Practice 2004; 4: 141–147
  • Levine W C, Dicker L W, Devine O, Mosure D J. Indirect estimation of Chlamydia screening coverage using public health surveillance data. Am J Epidemiol 2004; 160: 91–96
  • Khan A, Fortenberry J D, Juliar B E, Tu W, Orr D P, Batteiger B E. The prevalence of Chlamydia, gonorrhoea, and trichomonas in sexual partnerships: implications for partner notification and treatment. Sex Trans Dies 2005; 32: 260–264
  • Leone P. Reducing risk of transmitting genital herpes: advances in understanding and therapy. Curr Med Res Opin 2005; 21: 1577–1582
  • Genc M, Onderdonk A B, Vardhana S, Delaney M L, Norwitz E R, Tuomala R E, Paraskevas L R, Witkin S S, MAP Study Group. Polymorphism in intron 2 of the interleukin-1 receptor to vaginal flora, and subsequent preterm birth. Am J Obstet Gynecol 2004; 191: 1324–1330
  • Ross J D. Is Mycoplasma genitalium a cause of pelvic inflammatory disease?. Infect Dis Clin North Am 2005; 19: 407–413
  • Oakeshott P, Hay P, Taylor-Robinson D, Dohn B, Kerry S, Jensen J S. Prevalence of Mycoplasma genitalium in early pregnancy and relationship between its presence and pregnancy outcome. Br J Obstet Gynaecol 2004; 111: 1464–1467
  • Jurstrand M, Jensen J S, Fredlund H, Falk L, Molling P. Detection of Mycoplasma genitaliumin urogenital specimens by real-time PCR and by conventional PCR assay. J Med Microbiol 2005; 54: 23–29
  • Bjomelius E, Jensen J S, Lidbrink P. Conjunctivitis associated with Mycoplasma genitalium. Clin Infect Dis 2004; 39: e67–e69
  • Falk L, Fredlund H, Jensen J S. Tetracycline treatment does not eradicate Mycoplasma genitalium. Sex Trans Dis 2003; 79: 318–319
  • Spaargaren J, Fennema H S, Morse S A, de Vries H J, Coutinho R A. New Lymphogranuloma venereum Chlamydia trachomatis LGV variant. Emerg Infect Dis 2005; 11: 1090–1092
  • Schachter J, Moncada J. Lymphogranuloma venereum: how to turn an academic disease into an outbreak of a new disease? Start looking. Sex Trans Dis 2005; 32: 331–332
  • Karumudi U R, Augenbraun M. Syphilis and HIV: a dangerous duo. Expert Rev Anti Infect Ther 2005; 3: 825–831
  • John M, Keller M J, Fam E H, Cheshenko N, Hogarty K, Kasowitz A, et al. Cervicovaginal secretions contribute to innate resistance to herpes simplex virus infection. J Infect Dis 2005; 192: 1731–1740
  • Mårdh P -A, Persson K. Is there a need for rescreening of patients treated for genital chlamydial infections?. Int J STD AIDS 2002; 13: 318–322
  • Ryder N Y, Ivens D. Male urethral gonorrhoea—5,700 pound for a positive test. Int J STD AIDS 2005; 16: 638
  • Wallin K L, Wiklund F, Ängström T, Bergman F, Stendahl U, Wadell G. Type-specific persistence of human papillomavirus DNA before the development of invasive cancer. New Engl Med 1999; 341: 1633–1638
  • Lehtinen M, Paavonen J. Vaccination against human papillomaviruses shows great promise. Lancet 2004; 364: 1731–1732
  • Dillner J, Brown D R. Can genital-tract human papillomavirus infection and cervical cancer be prevented with a vaccine?. Expert Rev Mol Med 2005; 9: 1–21
  • Luostarinen, Letinen M, Bjorge T, Abeler V, Hakama M, Haakama M, et al. Joint effects of different human papillomaviruses and Chlamydia trachomatis infections on risk of squamous cancer of the cervix uteri. Eur J Cancer 2004; 40: 1058–1065
  • Silins I, Ryd W W, Strand A, Wadell G, Tornberg S, Hansson B G, et al. Chlamydia trachomatis infection and persistence of human papillomavirus. Int J Cancer 2005; 116: 110–115
  • Källén B A, Otterblad Olausson P, Danielsson B R. Is erythromycin therapy teratogenic in humans?. Reprod Toxocol 2005; 20: 209–214
  • Genc M, Mårdh P -A. Cost-effectiveness treatment of gonorrhoea, including co-infection with Chlamydia trachomatis. Pharmaoeconomics 1997; 12: 374–383
  • Hopkin E S, Coleman C, Kelleher M, Keating S, Clarke S, O'Connell B, et al. Increasing resistance to ciprofloxacin among isolates of Neisseria gonorrhoeae in Dublin. Ir Med J 2005; 98: 208–209
  • Somani J, Bhullar V B, Workowski K A, Farsky C E, Black C M. Multiple drug-resistant Chlamydia trachomatis associated with clinical treatment failure. J Infect Dis 2000; 181: 1421–1427
  • Austin M N, Beigi R H, Meyn L A, Hillier S L. Microbiologic response to treatment of bacterial vaginosis with topical clindamycin or metronidazole. J Clin Microbiol 2005; 43: 4492–4497
  • Mårdh P -A, Szillar I, Tolbert V, Novikova N, Kristof K, Rodrigues C, Pina-Vaz C, Martinez-de-Oliviera J. Candida glabrata with special reference to European epidemiology. Review and presentation of new data. It J Gynaecol Obstet 2005; 17: 73–80
  • Pina-Vaz C, Rodrigues A C, Costa-de-Oliveira S, Ricardo E, Mårdh P -A. Potent synergic effect between ibuprofen and azoles on Candida resulting from blockade of efflux pumps as determined by FUN-1 staining and flow cytometry. J Antimicrob Chemother 2005; 56: 678–685

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.